About Us
The Arc of Plant BioTech Supplements
For millennia people have relied upon the functional properties of Medicinal Plants to provide non-invasive solutions. Many of these naturally derived remedies, including traditional medicinal herbs and pharmacological sources, are still in use today.
In modern times, plant biotechnology ushered in sustainable access to biofunctional molecules including long chain polyunsaturated fatty acids (e.g. Nutriterra® Total Omega-3, GLASO™) for a wide range of health benefits, enzyme replacement therapies (e.g. Elelyso and Elfabrio), and soon naturally-derived sources for lactoferrin, collagen, sweeteners, enzymes, and growth factor variants are entering the market to provide supplements for metabolic optimization.
As demand for accessible metabolic solutions continues to outpace traditional approaches, Viridis BioSciences introduces a sustainable, affordable alternative: naturally-derived oral Glucagon like peptide-1 Receptor Agonists (GLP-1 RAs) supplements to fuel intrinsic health. Our platform bridges biotechnology and daily nutrition to maintain health and weight.
.png)
_edited.jpg)
Our Innovation - Daily health powered by the sun for affordable wellness.
Viridis BioSciences is built on four pillars: field-to-the-shelf products offering unprecedented scalability, stability in the seed as a natural supply, efficient recovery for affordable access, and effective delivery as a daily supplement.
​​​​​
Our proprietary approach combines GLP-1 RAs with oral delivery and is now positioned for overall health benefits and weight maintenance. We are leveraging our global partnerships and a lean business model to drive near‑term value with accessible, plant-derived products that support rising demand for metabolic health.
​​
Concurrently, we will expand our product pipeline into adjacent markets to advance biofunctional molecules that will strengthen long‑term growth and portfolio diversification. Through continuous innovation, Viridis BioSciences is building sustainable impact across health and biosecurity in the new bioeconomy.
Who We Are
Backed by more than a half century of collective expertise, our team has pioneered sustainable and accessible naturally derived biofunctional molecules across human health. With over 300 patents and multiple products brought to market, our founders bring deep experience in scaling breakthrough technologies. Today our next‑generation platform* is positioned to address one of the largest unmet needs in the new era of metabolic health through a plant-based approach.
​
Our innovation is strengthened by a long-standing network of world-class researchers and developers with expertise in advancing plant-based supplements toward commercial readiness. Together we combine scientific rigor with decades of commercialization experience to support development of ingenious metabolic health solutions to support glycemic management.
​
*Patent(s) pending
The Opportunity - Where plant BioTech meets an emerging unmet need.
Global demand for affordable, accessible solutions in weight management and metabolic health is accelerating at an unprecedented speed. Injectable GLP‑1 therapies have demonstrated strong market pull, but they remain costly, complex to access, and difficult to sustain long term health benefits. Oral GLP‑1 therapies face similar barriers to market entry and reimbursement coverage. In both cases, millions are left without practical options for the long‑term after achieving their weight loss goals. Under these circumstances, an accessible and affordable solution for weight loss maintenance remains elusive once treatment ceases or is no longer covered.
​
Viridis BioSciences is uniquely positioned to address this emerging gap through a new category of plant‑made oral nutritional supplements that support the benefits of GLP‑1 RAs. Our products are positioned to provide an accessible substitute in a rapidly expanding multi-billion-dollar landscape.
This opportunity covers overlapping health and biosecurity sectors, enabling near‑term revenue alongside long‑term growth through platform expansion, licensing, and global partnerships. By bridging biotechnology and nutrition, Viridis BioSciences can shape the next era of metabolic innovation.
Our Vision
Affordable biotech. Accessible health. Green innovation.
Viridis BioSciences is reimagining how biotechnology delivers human health solutions that are affordable, accessible, and sustainable. By transforming powerful biofunctional molecules into convenient plant-derived oral supplements, we are opening a new category of daily supplements that empowers people to support their health and weight without the high costs, injections, or barriers of conventional approaches. Guided by decades of innovation and global partnerships, Viridis BioSciences will ignite near‑term value creation, expand into new markets, and continuously innovate to capture multiple revenue streams in the new bioeconomy. Our mission is to redefine how recombinant proteins can transform health and strengthen global biosecurity.
Scalability
Viridis is designed for rapid entry into the market through a clear, near-term revenue strategy. With products positioned as dietary supplements, our model lowers barriers, accelerates timelines, and enables early commercial traction across multiple product concepts.
.png)
Momentum
Viridis operates in one of the fastest-growing sectors in global health: metabolic support and weight management. Our platform and oral technology align with rising demand for accessible, non-injectable solutions, offering investors a credible foothold in a rapidly expanding category.
Efficiency
Our plant-based system uses scalable crop-grown production rather than energy-intensive fermentation. This approach dramatically reduces cost and complexity, allowing us to bring biofunctional molecules to consumers at price points that all can afford. Furthermore, downstream bioprocessing leverages existing infrastructure and off-the-shelf equipment in food manufacture.
.png)
Glycemic Management
As our business expands, other product concepts will converge on what are considered two interrelated escalating global issues: obesity and diabetes. Our current and future supplements will focus directly on support for glycemic management to address the devastating consequences these health issues pose.
.png)